Agilent To Sell Resolution Bioscience To Exact Sciences For Undisclosed Sum

(RTTNews) - Agilent Technologies, Inc. (A) and Exact Sciences Corp. (EXAS) said on Tuesday that they have inked a deal for the sale of Resolution Bioscience to Exact Sciences., for an undisclosed sum.

Resolution Bioscience is a developer of next-generation sequencing-based precision oncology solutions.

Sam Raha, Senior Vice President at Agilent, said: "Exact is a leading centralized laboratory for advanced cancer diagnostic testing with significant capabilities and resources in this area, which makes Resolution Bioscience a strategic fit for them. This agreement will enable the talented Resolution Bioscience team to continue their work advancing diagnostic solutions for their customers and patients, a very positive outcome of this transaction."